CCN1 and plasma cell myeloma: We further performed blocking experiments with anti-integrin β1, β2, β3, β7 antibodies, as these integrins are described as being expressed on myeloma cells[43], and integrins α6β1 and αMβ2, which interact with the CT-domain of CCN1[10].